Viewing Study NCT04635995


Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2026-01-01 @ 3:28 AM
Study NCT ID: NCT04635995
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-31
First Post: 2020-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Sponsor: Lyvgen Biopharma Holdings Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module